| 000 | 05307cam a2200457Ii 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_Medicine_2017 | ||
| 999 |
_c95795 _d95795 _x1 |
||
| 001 | 95795 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112722.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170411s2017 sz ob 001 0 eng d | ||
| 020 |
_a331952190X _q(electronic bk.) |
||
| 020 |
_a9783319521909 _q(electronic bk.) |
||
| 020 | _z3319521888 | ||
| 020 | _z9783319521886 | ||
| 040 |
_aN$T _cN$T _dN$T _dEBLCP _dGW5XE _dYDX _dUAB _dMERER _dESU _dAZU _dUPM _dIOG _dOCLCQ _dVT2 _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRJ313 _b2017 EB |
|
| 245 | 0 | 0 |
_aRetinopathy of prematurity : _bcurrent diagnosis and management _cB. Andrés Kychenthal, S. Paola Dorta, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c2017. |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 500 | _aSpringerLink | ||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _aContributors; 1 Pathophysiology of ROP; Retinal Vascular Development; Term Versus Preterm Birth; Oxygen; Oxygen Stresses and Oxidation; Oxygen Trials; Nutrition; Phases of ROP and Phases of Experimental Oxygen-Induced Retinopathy; Role of VEGF and Angiogenesis; Role of Anemia and Erythropoietin; Role of Oxidation, Inflammation, and Angiogenesis; VEGF Signaling; The Role of Light; Summary; References; 2 Classification of ROP; Zone; Stage; Plus Disease; Pre-threshold; Threshold; Early Treatment ROP Trial; References. | |
| 505 | 8 | _a3 Retinopathy of Prematurity Screening-Current and Future ConsiderationsIntroduction; Screening Guidelines; Which Infants Need to be Screened?; High-Income Countries; Low- and Middle-Income Countries; When to Screen?; ROP Natural History; When to Start Screening?; When Screening Can Be Safely Terminated; Telemedicine Approach to ROP; Future Technology of ROP Screening; References; 4 Optical Coherence Tomography and Wide-Field Fluorescein Angiography in Retinopathy of Prematurity; Abstract; Optical Coherence Tomography; What Is Optical Coherence Tomography? | |
| 505 | 8 | _a8 Pharmacomodulation in the Treatment of Retinopathy of PrematurityAbstract; Normal Retina and Vasculature; Background of ROP; Standard Versus Aggressive Posterior ROP; Smoldering ROP; History of VEGF; Type 1 ROP-The CRYO-ROP Study; The ET-ROP Study; Spontaneous Regression Complications; The BEAT-ROP Study; Treatment for Typical ROP; Pharmacomodulation Versus Laser; Systemic Modulation in ROP; Current Anti-VEGF Treatment Guidelines; When to Treat with Anti-VEGF; ROP Crunch; Different Types of Anti-VEGF; When to Treat with Laser; Considering Dual Treatment; Anti-VEGF Dose; Injection Technique. | |
| 505 | 8 | _aAdapting Optical Coherence Tomography from Adult to InfantDevelopmental Retinal and Optic Nerve Microanatomy Observed on Optical Coherence Tomography in Preterm Infants; Optical Coherence Tomography in ROP; Wide Field Imaging and Fluorescein Angiography; What Is Wide Field Imaging?; Wide Field Imaging and ROP Telemedicine; Wide-Field Fluorescein Angiography and ROP; Conclusion; References; 5 Remote Imaging and Smart Software for ROP Screening; Virtual Pediatric Retinal Reading Center; References; 6 Aggressive Posterior Retinopathy of Prematurity (APROP). | |
| 505 | 8 | _aPart 1 Critiques of the R-ICROP Description of APROPPart 2: Practical Diagnosis and Management of APROP; Part 3: Additional forms of APROP; Part 4: Treatment of APROP; Appendix: Additional Aspects in the Development of APROP; References; 7 Photocoagulation for Retinopathy of Prematurity; Abstract; General Considerations; Current Indications for Laser Treatment of ROP; Advantages of Laser Versus Cryotherapy; Complications of Laser Treatment for ROP; How to Perform Indirect Laser to Treat Type 1 ROP; Laser Photocoagulation in the Anti-VEGF Area; References. | |
| 520 | 3 | _aThis clinically oriented book is devoted to the diagnosis and treatment of retinopathy of prematurity (ROP), a leading cause of childhood blindness. World-renowned experts in the field discuss epidemiologic and pathogenic aspects of the disease. The staging and classification of ROP are explained in detail, and guidance is provided on appropriate anesthesia. The state of the art in imaging of ROP is described and illustrated, with coverage of the advances in ophthalmic imaging technology and telemedicine that have revolutionized pediatric retinal examinations and contributed significantly in elucidating the pathophysiology of ROP and improving diagnosis and treatment. Treatment indications and therapeutic alternatives, including the use of antiproliferative drugs, are addressed in separate chapters, supplying the reader with the most up-to-date knowledge in the field. | |
| 588 | 0 | _aVendor-supplied metadata. | |
| 650 | 7 |
_2embne _9190667 _aRetina _xEnfermedades |
|
| 700 | 1 |
_aDorta, S. Paola, _eeditor literario |
|
| 700 | 1 |
_aKychenthal, B. Andrés, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-52190-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2018 _dz _e- _zSI |
||